Walk into most clinics offering injectable treatments and the first question you’ll be asked is: which product would you like? This product or that one. This filler or another. As if the choice between brands explained the outcome. It doesn’t.
The truth is more uncomfortable. Most outcomes come from how an injection is planned, where it’s placed, and why. The product is closer to the last variable than the first. And yet the entire conversation in mainstream aesthetic medicine has been organised around brand recognition for two decades.
This isn’t an accident. Brand-led care is easier to scale. It is easier to teach junior practitioners. It produces a more predictable revenue per patient. And it removes the most difficult part of injectable medicine, which is the part that requires sustained study: human facial anatomy.
The protocol problem
Most clinics use what’s called a protocol-driven approach. Protocols are sets of injection points and dosages, mapped onto a generic face, that produce a predictable result in the average patient. They exist because they are safe enough, they are teachable, and they reduce variability between practitioners.
The trade-off is that no patient is the average patient. Faces differ in muscle bulk, fat compartment volume, bone projection, skin laxity and dynamic movement. A protocol that produces a beautiful result on one patient produces a flat, frozen, or strangely lifted result on another. The patient is told this is the expected outcome. It isn’t.
What anatomy-led actually means
Anatomy-led injection is not a marketing term. It refers to a specific clinical practice in which every patient is assessed individually before a single injection point is chosen. The assessment includes:
- Static and dynamic facial analysis at rest and through full expression
- Palpation to identify muscle bulk, attachment patterns and asymmetries
- Bone landmark mapping to establish proportional anchor points
- Review of any prior treatment, including filler that may still be in tissue
- Discussion of the patient’s expression patterns, from how they speak to how they smile
Only after this is complete are injection points chosen. They may overlap with a standard protocol, but more often they don’t. The dose at each point is also calibrated to the individual, not to the syringe size on the tray.
How we approach it at DROM
Every patient who comes to DROM for injectable treatment goes through an in-person consultation before any procedure is booked. The consultation is not a sales conversation. It is a clinical one. We will tell you, often, that an injectable treatment is not the right choice for what you’re describing. Sometimes the answer is energy-based. Sometimes it is skincare. Sometimes it is patience.
When injectable treatment is the right choice, we map the plan to your individual anatomy and review it with you before any product is selected. The choice of product is decided last, based on what behaves best in the tissue we’re working with, not based on what’s on offer that month.
What this means for you
If you’ve had injectable treatment before and felt that something looked off, the brand was almost certainly not the cause. Ask the next clinic you visit to walk you through where they would inject and why, before they tell you what they would use. The answer will tell you which kind of practice you’re in.
The face you came in with is the most important variable in the room. Everything else is secondary.
When a protocol fails, the patient learns to live with the result. When anatomy-led care fails, the practitioner has to ask harder questions and start again.
— Dr. Ozlem Mutlu Cetin
